Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Bimekizumab effectively treated a man's chronic beard hair loss.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Adalimumab improved folliculitis decalvans in most patients.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Immunotherapy can help treat severe alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The hydrogel helps heal diabetic wounds faster by reducing inflammation.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Hydrogel microneedles offer a promising, minimally invasive way to treat diseases like cancer and hair loss, but need improvements in strength and standardization.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

The HCR gene contributes to psoriasis risk.

Nanotechnology can improve tissue healing by controlling immune responses.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Immunological treatment improved both neuropathy and alopecia.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Machine learning helps find new uses for existing drugs, improving healthcare.

The nano-carrier makes etoposide safer and more effective against lung cancer.